NILOTINIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 63 adverse event reports in the FDA FAERS database where NILOTINIB was used for Neoplasm malignant.
Most Reported Side Effects for NILOTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,667 | 11.5% | 2,661 | 189 |
| Fatigue | 1,679 | 7.3% | 240 | 380 |
| Rash | 1,250 | 5.4% | 27 | 199 |
| Nausea | 1,180 | 5.1% | 173 | 271 |
| Headache | 1,177 | 5.1% | 208 | 296 |
| Pain | 1,169 | 5.1% | 106 | 270 |
| Dyspnoea | 1,070 | 4.6% | 339 | 402 |
| Diarrhoea | 998 | 4.3% | 245 | 238 |
| Drug ineffective | 992 | 4.3% | 99 | 169 |
| Malaise | 961 | 4.2% | 239 | 290 |
| Arthralgia | 925 | 4.0% | 223 | 168 |
| Pyrexia | 909 | 3.9% | 284 | 372 |
| Pruritus | 900 | 3.9% | 205 | 145 |
| Asthenia | 853 | 3.7% | 273 | 272 |
| Vomiting | 830 | 3.6% | 208 | 291 |
Other Indications for NILOTINIB
Chronic myeloid leukaemia (14,842)
Product used for unknown indication (5,339)
Acute lymphocytic leukaemia (419)
Philadelphia positive chronic myeloid leukaemia (364)
Leukaemia (203)
Philadelphia chromosome positive (153)
Myeloid leukaemia (105)
Gastrointestinal stromal tumour (104)
Acute myeloid leukaemia (59)
Blast crisis in myelogenous leukaemia (39)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)